Investors have long been attracted by the innovation and potentially large returns in the life sciences and biotechnology sector. In the past five years, biotech has emerged as one of the best performing technology sectors, according to numerous indices and funds. One leading biotech index, the Nasdaq Biotechnology Index, was recently up 35% over the last five years.

There are good reasons to consider biotech investments. Recent breakthroughs with new drugs and devices are boosting the productivity of medical treatment, saving and extending lives. Healthcare is one of the largest growing segments of the global economy. In addition, the biotech sector remained a relative port in the storm during the financial crisis of 2008, declining less than other markets. This is because it is viewed by investors as a long-term market of medical innovation, rather than a market susceptible to short-term swings in the economy.

In this report, we review the top trends in the biotech sector, break down some of the leading market segments, and provide a list of the leading companies. In addition the report includes a guide to entering the market via ETFs, mutual funds, or a model portfolio of individual biotech stocks that we have selected.

This comprehensive report aims to give you the big picture on the biotech market.

Table of Contents:

• Introduction: Life-Sciences Innovation Overview
  - Pg. 2
• The Top Biotech Trends
  - Pg. 3
• Market Overview: Key Markets and Companies
  - Pg. 5
• Top Biotech Picks: A Model Portfolio
  - Pg. 11
• Biotech Mutual Funds and ETFs
  - Pg. 12
• Conclusion: Biotech a Key Sector for Innovation
  - Pg. 15
• Appendix: Financial Metrics
  - Pg. 16